{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:03:03Z","timestamp":1785164583597,"version":"3.55.0"},"reference-count":37,"publisher":"Universa BV","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AGEB"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:p>Hepatic encephalopathy (HE) is one of the most severe complications following transjugular intrahepatic portosystemic shunt (TIPS). The identification and treatment of risk factors associated with the development of this complication may reduce the incidence and severity of post-TIPS HE. Several studies have demonstrated that the nutritional status plays a major role in the outcome of the cirrhotic population, particularly those who are decompensated. Although scarce, there are also studies highlighting an association between poor nutritional status, sarcopenia, fragile status, and post-TIPS HE. If these data are confirmed, nutritional support could become a means for decreasing this complication, thereby enhancing the use of TIPs in the treatment of refractory ascites or variceal bleeding. In this review, we will discuss the pathogenesis of HE, the data that supports an association with sarcopenia, nutritional status and frailty and the implications that these conditions have on the use of TIPS in clinical practice.<\/jats:p>","DOI":"10.51821\/86.2.11430","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T13:28:32Z","timestamp":1689686912000},"page":"318-322","source":"Crossref","is-referenced-by-count":4,"title":["Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt \u2013 TIPS, and strategies to improve the outcomes"],"prefix":"10.51821","volume":"86","author":[{"given":"M","family":"Berenguer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27062","published-online":{"date-parts":[[2023,6]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"VILSTRUP H, AMODIO P, BAJAJ J, CORDOBA J, FERENCI P, MULLEN KD, WEISSENBORN K, WONG P. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014; 60:715-735.","DOI":"10.1002\/hep.27210"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"PATIDAR KR, BAJAJ JS. Covert and overt hepatic encephalopathy: diagnosis and management. Clin Gastroenterol Hepatol.2015;13(12):2048-2061.","DOI":"10.1016\/j.cgh.2015.06.039"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"FALLAHZADEH MA, RAHIMI RS. Hepatic Encephalopathy and Nutrition Influences: A Narrative Review. Nutr Clin Pract. 2020 feb;35(1):36-48.","DOI":"10.1002\/ncp.10458"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"BAI M, QI X, YANG Z, YIN Z, NIE Y, YUAN S, et al. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol. 2011; 26:943-951.","DOI":"10.1111\/j.1440-1746.2011.06663.x"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"FAGIUOLI S, BRUNO R, DEBERNARDI VENON W, VENON W, SCHEPIS F, VIZZUTTI F et al. Consensus conference on TIPS management: techniques, indications, contraindications. Dig Liver Dis. 2017; 49:121-137.","DOI":"10.1016\/j.dld.2016.10.011"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"RIGGIO O, ANGELONI S, SALVATORI FM, DE SANTIS A, CERINI F, FARCOMENI A et al. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol. 2008; 103:2738-2746","DOI":"10.1111\/j.1572-0241.2008.02102.x"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"CORONADO WM, JU C, BULLEN J, KAPOOR B. Predictors of occurrence and risk of hepatic encephalopathy after TIPS creation: a 15-year experience. Cardiovasc Intervent Radiol. 2020; 43:1156-1164","DOI":"10.1007\/s00270-020-02512-7"},{"key":"ref7","unstructured":"TEMMERMAN F, LALEMAN W, MALEUX G, NEVENS F. Treatment of recurrent severe hepatic encephalopathy in patients with large porto- collaterals shunts or transjugular portosystemic shunt. Acta Gastroenterol Belg 2020; 83(1):67-71."},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"TANDON P, MONTANO-LOZA AJ, LAI JC, DASARATHY S, MERLI M. Sarcopenia and frailty in decompensated cirrhosis. J Hepatol. 2021 Jul;75 Suppl 1(Suppl 1): S147-S162","DOI":"10.1016\/j.jhep.2021.01.025"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"PUCHADES-RENAU L, HERRERAS-L\u00d3PEZ J, IRANZO, M, IRANZO M\u00c0, CEZ\u00d3N SERRANO N, DI MAIRA T, BERENGUER M. Frailty and sarcopenia in acute on chronic liver failure. Hepatol Communications 2021; 5(8): 1333-1347","DOI":"10.1002\/hep4.1722"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"MONTANO-LOZA A. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol. 2014; 20:8061-8071.","DOI":"10.3748\/wjg.v20.i25.8061"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"MERLI M, Snapshots in J Hepatol: Nutrition in cirrhosis: Dos and Don\u2019ts; J Hepatol, 2020; 73:1563-1565.","DOI":"10.1016\/j.jhep.2020.07.019"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"DUMONT C, WUESTENBERGHS F, LANTHIER N, PIESSEVAUX H, DAHLQVIST G. Malnutrition is highly prevalent in hospitalized cirrhotic patients and associates with a poor outcome. Acta Gastroenterol Belg 2022; 85(2):311-319.","DOI":"10.51821\/85.2.9016"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"GOFFAUX A, DELORME A, DAHLQVIST G, LANTHIER N. Improving the prognosis before and after liver transplantation: Is muscle a game changer? World J Gastroenterol 2022;28(40):5807-5817","DOI":"10.3748\/wjg.v28.i40.5807"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"HENIN G, LANTHIER N, DAHLQVIST G. Pathophysiological changes of the liver-muscle axis in end-stage liver disease: what is the right target? Acta Gastroenterol Belg 2022; 85(4):611-624.","DOI":"10.51821\/85.4.10899"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"HUISMAN EJ, TRIP EJ, SIERSEMA PD, VAN HOEK B, VAN ERPECUM KJ. Protein energy malnutrition predicts complications in liver cirrhosis. Eur J Gastroenterol Hepatol 2011; 23(11):982-9.","DOI":"10.1097\/meg.0b013e32834aa4bb"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"MERLI M, GIUSTO M, LUCIDI C, GIANNELLI V, PENTASSUGLIO I, DI GREGORIO V, LATTANZI B, RIGGIO O. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study. Metab Brain Dis. 2013 Jun;28(2):281-4.","DOI":"10.1007\/s11011-012-9365-z"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"KALAITZAKIS E, OLSSON R, HENFRIDSSON P, HUGOSSON I,  BENGTSSON M, JALAN R, BJ\u00d6RNSSON E. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis.  Liver Int 2007;27(9):1194-1201","DOI":"10.1111\/j.1478-3231.2007.01562.x"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"HANAI T, SHIRAKI M, WATANABE S, KOCHI T, IMAI K, SUETSUGU A et al. Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis. Hepatol Res 2017;47(13):1359-1367.","DOI":"10.1111\/hepr.12873"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"AUGUSTI L, FRANZONI LC, SANTOS LA, LIMA TB, IETSUGU MV, KOGA KH et al. Lower values of handgrip strength and adductor pollicis muscle thickness are associated with hepatic encephalopathy manifestations in cirrhotic patients. Metab Brain Dis 2016; 31:909-915.","DOI":"10.1007\/s11011-016-9828-8"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"LI J, FENG D, PANG N, ZHAO C, GAO L, LIU S, LI L. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt. Clin Nutr 2022; 41(2):560-566.","DOI":"10.1016\/j.clnu.2021.12.036"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"S\u00d6R\u00d6S P, B\u00d6TTCHER J, WEISSENBORN K, SELBERG O, M\u00dcLLER MJ. Malnutrition and hypermetabolism are not risk factors for the presence of hepatic encephalopathy: a cross-sectional study. J Gastroenterol Hepatol 2008;23(4):606-610.","DOI":"10.1111\/j.1440-1746.2007.05222.x"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"MEZA-JUNCO J, MONTANO-LOZA AJ, BARACOS VE, PRADO CM, BAIN VG, BEAUMONT C et al. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol 2013;47 (10):861-870.","DOI":"10.1097\/mcg.0b013e318293a825"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"MONTANO-LOZA AJ, MEZA-JUNCO J, PRADO CM, LIEFFERS JR, BARACOS VE, BAIN VG, SAWYER MB. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012;10(2):166-173.","DOI":"10.1016\/j.cgh.2011.08.028"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"NARDELLI S, LATTANZI B, TORRISI S, GRECO F, FARCOMENI A, GIOIA S et al. Sarcopenia is risk factor for development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement. Clin Gastroenterol Hepatol 2017;15(6):934-936.","DOI":"10.1016\/j.cgh.2016.10.028"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"BHANJI RA, MOCTEZUMA-VELAZQUEZ C., DUARTE-ROJO A, EBADI M, GHOSH S, ROSE C. et al., Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis. Hepatol Int 2018;12:377-386.","DOI":"10.1007\/s12072-018-9875-9"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"CHANG KV, CHEN JD, WU WT, HUANG KC, LIN HY, HAN DS. Is sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta-analysis. J Formos Med Assoc 2019; 118(4):833-842","DOI":"10.1016\/j.jfma.2018.09.011"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"TSIEN C, SHAH SN, MCCULLOUGH AJ, DASARATHY S. Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent. Eur J Gastroenterol Hepatol 2013;25(1):85-93.","DOI":"10.1097\/meg.0b013e328359a759"},{"key":"ref28","unstructured":"LUO L, FU S, ZHANG Y, WANG J. Early diet intervention to reduce the incidence of hepatic encephalopathy in cirrhosis patients: post-transjugular Intrahepatic Portosystemic Shunt (TIPS) findings. Asia Pac J Clin Nutr 2016;25(3):497-503"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"GIOIA S, NARDELLI S, FACCIOLI J, RIDOLA L. Post TIPS hepatic encephalopathy: Look at muscle and fat! Clin Nutr 2022;41(5):1150.","DOI":"10.1016\/j.clnu.2022.03.003"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"GIOIA S, RIDOLA L, CRISTOFARO L, MERLI M, FACCIOLI J, RIGGIO O, NARDELLI S. The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Liver Int 2021; 41(12): 2965-2973.","DOI":"10.1111\/liv.15060"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"GIOIA S, MERLI M, NARDELLI S, LATTANZI B, PITOCCHI F, RIDOLA L, RIGGIO O. The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS. Liver Int. 2019; 39(5):871-877.","DOI":"10.1111\/liv.14050"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"MAHARSHI S, SHARMA BC, SACHDEVA S, SRIVASTAVA S, SHARMA P. Efficacy of Nutritional Therapy for Patients with Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial. Clin Gastroenterol Hepatol 2016; 14(3):454-460)","DOI":"10.1016\/j.cgh.2015.09.028"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"SARASWAT VA; KUMAR K. Untangling the Web of Malnutrition, Sarcopenia, and Frailty in Chronic Liver Disease.J Clin Exp hep 2022; 12 (2): 268","DOI":"10.1016\/j.jceh.2022.02.002"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"VINAIXA C, MART\u00cdNEZ PALLI G, MILIKEN D, MILLIKEN D, SELLERS D, DHARANCY S et al. on behalf of ERAS4OLT.org Working Group: The role of prehabilitation on short-term outcomes after liver transplantation: A review of the literature and expert panel recommendations. Clin Transplant 2022; 36(10): e14686","DOI":"10.1111\/ctr.14686"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"TINGUELY P, MORARE N, RAMIREZ-DEL VAL A, BERENGUER M, NIEMANN CU, POLLOK JM et al. Enhanced recovery after surgery programs improve short-term outcomes after liver transplantation-A systematic review and meta-analysis. Clin Transplant 2021; 35(11): e14453.","DOI":"10.1111\/ctr.14453"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"POLLOK JM, TINGUELY P, BERENGUER M, NIEMANN CU, RAPTIS DA, SPIRO M, et al on behalf of ERAS4OLT.org collaborative. Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference. Lancet Gastroenterol Hepatol 2023; 8(1):81-94.","DOI":"10.1016\/S2468-1253(22)00268-0"}],"container-title":["Acta Gastro Enterologica Belgica"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T13:30:02Z","timestamp":1689687002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ageb.be\/ageb-journal\/ageb-volume\/ageb-article\/2097\/Nutritional%20status%20in%20hepatic%20encephalopathy%20and%20transjugular%20intrahepatic%20portosystemic%20shunt%20%E2%80%93%20TIPS,%20and%20strategies%20to%20improve%20the%20outcomes\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6]]},"published-print":{"date-parts":[[2023,6]]}},"URL":"https:\/\/doi.org\/10.51821\/86.2.11430","relation":{},"ISSN":["1784-3227"],"issn-type":[{"value":"1784-3227","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}